These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 320494)

  • 21. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 22. [GABA derivative in the treatment of spasticity in patients with multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1973; 7(3):413-8. PubMed ID: 4714197
    [No Abstract]   [Full Text] [Related]  

  • 23. Dantrolene sodium (Dantrium-Eaton) for relief of spasticity.
    Nelson JR
    West J Med; 1975 Aug; 123(2):131. PubMed ID: 1179721
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 25. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E; Martensson A
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site of action of dantrolene in frog sartorius muscle.
    Putney JW; Biancri CP
    J Pharmacol Exp Ther; 1974 Apr; 189(1):202-12. PubMed ID: 4545054
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES; Soll RW; Loewenson RB
    JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254
    [No Abstract]   [Full Text] [Related]  

  • 28. Dantrium--torque induced motion ("TIM"). Analysis in normal subjects.
    Walsh EG
    Agressologie; 1977; 18 Spec No():31-3. PubMed ID: 900358
    [No Abstract]   [Full Text] [Related]  

  • 29. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 30. [C34.647-Ba (Lioresal) in the treatment of hypertonic manifestations of multiple sclerosis].
    Ketelaer P; Tyberghein JM; Ketelaer CJ
    Brux Med; 1973 Nov; 53(11):675-81. PubMed ID: 4769203
    [No Abstract]   [Full Text] [Related]  

  • 31. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
    Weiser R; Terenty T; Hudgson P; Weightman D
    Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of dantrolene sodium on spasticity associated with hemiplegia.
    Steinberg FU; Ferguson KL
    J Am Geriatr Soc; 1975 Feb; 23(2):70-3. PubMed ID: 1141624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of dantrolene sodium in the treatment of spastic and dystonic syndromes].
    Fraioli B; Guglielmi G; Baldassarre L
    Riv Neurol; 1976; 46(4):333-50. PubMed ID: 1023344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
    Nickel B; Jakovlev V; Szelenyi I
    Arzneimittelforschung; 1990 Aug; 40(8):909-11. PubMed ID: 2242082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Horne ML
    JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report.
    Sturgill EL; Wittwer RL
    A A Pract; 2018 Jul; 11(1):25-27. PubMed ID: 29851691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of electromyographic studies with central muscle relaxants--feasibility of objectivization and standardization].
    Ollinger H; Gruber J; Singer F
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Jun; 16(2):104-7. PubMed ID: 3930209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of spasticity with dantrolene sodium.
    Mayer N; Necomber SA; Herman R
    Am J Phys Med; 1973 Feb; 52(1):18-29. PubMed ID: 4685519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.